Variable interatrial conduction illustrated in a hypertrophic cardiomyopathy population
- PMID: 17617068
- PMCID: PMC6932290
- DOI: 10.1111/j.1542-474X.2007.00166.x
Variable interatrial conduction illustrated in a hypertrophic cardiomyopathy population
Abstract
Background: Patients with hypertrophic cardiomyopathy (HCM) have a high incidence of atrial fibrillation. They also have a longer P-wave duration than healthy controls, indicating conduction alterations. Previous studies have demonstrated orthogonal P-wave morphology alterations in patients with paroxysmal atrial fibrillation. In the present study, the P-wave morphology of patients with HCM was compared with that of matched controls in order to explore the nature of the atrial conduction alterations.
Methods and results: A total of 65 patients (45 men, mean age 49 +/- 15) with HCM were included. The control population (n = 65) was age and gender matched (45 men, mean age 49 +/- 15). Five minutes of 12-lead ECG was recorded. The data were subsequently transformed to orthogonal lead data, and unfiltered signal-averaged P-wave analysis was performed. The P-wave duration was longer in the HCM patients compared to the controls (149 +/- 22 vs 130 +/- 16 ms, P < 0.0001). Examination of the P-wave morphology demonstrated changes in conduction patterns compatible with interatrial conduction block of varying severity in both groups, but a higher degree of interatrial block seen in the HCM population. These changes were most prominent in the Leads Y and Z.
Conclusion: The present study suggests that the longer P-wave duration observed in HCM patients may be explained by a higher prevalence of block in one or more of the interatrial conduction routes.
Figures



Similar articles
-
Paradoxical effects of interatrial conduction delay in a hypertrophic cardiomyopathy patient in the long-term: time is a great healer.J Cardiovasc Electrophysiol. 2011 May;22(5):587-9. doi: 10.1111/j.1540-8167.2010.01893.x. Epub 2010 Aug 31. J Cardiovasc Electrophysiol. 2011. PMID: 20812930
-
Risk for atrial fibrillation in patients with hypertrophic cardiomyopathy assessed by signal averaged P wave duration.Heart. 1997 Jul;78(1):44-9. doi: 10.1136/hrt.78.1.44. Heart. 1997. PMID: 9290401 Free PMC article.
-
The signal-averaged P wave duration: a rapid and noninvasive marker of risk of atrial fibrillation.J Am Coll Cardiol. 1993 Jun;21(7):1645-51. doi: 10.1016/0735-1097(93)90381-a. J Am Coll Cardiol. 1993. PMID: 8123070
-
Conduction velocity is reduced in the posterior wall of hypertrophic cardiomyopathy patients with normal bipolar voltage undergoing ablation for paroxysmal atrial fibrillation.J Interv Card Electrophysiol. 2024 Jan;67(1):203-210. doi: 10.1007/s10840-023-01533-9. Epub 2023 Mar 23. J Interv Card Electrophysiol. 2024. PMID: 36952090 Review.
-
Intra- and interatrial conduction abnormalities: hemodynamic and arrhythmic significance.J Interv Card Electrophysiol. 2018 Aug;52(3):293-302. doi: 10.1007/s10840-018-0413-4. Epub 2018 Aug 20. J Interv Card Electrophysiol. 2018. PMID: 30128800 Review.
Cited by
-
Prevalence of interatrial block in healthy school-aged children: definition by P-wave duration or morphological analysis.Ann Noninvasive Electrocardiol. 2010 Jan;15(1):17-25. doi: 10.1111/j.1542-474X.2009.00335.x. Ann Noninvasive Electrocardiol. 2010. PMID: 20146778 Free PMC article.
-
Deciphering hypertrophic cardiomyopathy with electrocardiography.Heart Fail Rev. 2022 Jul;27(4):1313-1323. doi: 10.1007/s10741-021-10147-0. Epub 2021 Jul 21. Heart Fail Rev. 2022. PMID: 34286451 Review.
-
P-wave morphology is associated with echocardiographic response to cardiac resynchronization therapy in MADIT-CRT patients.Ann Noninvasive Electrocardiol. 2013 Nov;18(6):510-8. doi: 10.1111/anec.12121. Ann Noninvasive Electrocardiol. 2013. PMID: 24303967 Free PMC article. Clinical Trial.
-
Electrocardiographic and Echocardiographic predictors of paroxysmal atrial fibrillation detected after ischemic stroke.BMC Cardiovasc Disord. 2016 Nov 3;16(1):209. doi: 10.1186/s12872-016-0384-2. BMC Cardiovasc Disord. 2016. PMID: 27809773 Free PMC article. Clinical Trial.
-
Progressive interatrial block associated with atrial fibrillation in a patient with hypertrophic cardiomyopathy.Ann Noninvasive Electrocardiol. 2017 May;22(3):e12403. doi: 10.1111/anec.12403. Epub 2016 Sep 11. Ann Noninvasive Electrocardiol. 2017. PMID: 27615799 Free PMC article.
References
-
- Maron BJ. Hypertrophic cardiomyopathy. Lancet 1997;350:127–133. - PubMed
-
- Olivotto I, Maron BJ, Cecchi F. Clinical significance of atrial fibrillation in hypertrophic cardiomyopathy. Curr Cardiol Rep 2001;3:141–146. - PubMed
-
- Maron BJ, McKenna WJ, Danielson GK, et al American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 2003;42:1687–1713. - PubMed
-
- Losi MA, Betocchi S, Aversa M, et al Determinants of atrial fibrillation development in patients with hypertrophic cardiomyopathy. Am J Cardiol 2004;94:895–900. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical